Terms: = Germ cell tumor AND GATA2, NFE1B, 2624, ENSG00000179348, MGC2306, P23769 AND Prognosis
3 results:
1. Overview of the 2022 WHO Classification of Pituitary Adenomas/Pituitary Neuroendocrine tumors: Clinical Practices, Controversies, and Perspectives.
Wan XY; Chen J; Wang JW; Liu YC; Shu K; Lei T
Curr Med Sci; 2022 Dec; 42(6):1111-1118. PubMed ID: 36544040
[TBL] [Abstract] [Full Text] [Related]
2. PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum.
Alhalabi KT; Stichel D; Sievers P; Peterziel H; Sommerkamp AC; Sturm D; Wittmann A; Sill M; Jäger N; Beck P; Pajtler KW; Snuderl M; Jour G; Delorenzo M; Martin AM; Levy A; Dalvi N; Hansford JR; Gottardo NG; Uro-Coste E; Maurage CA; Godfraind C; Vandenbos F; Pietsch T; Kramm C; Filippidou M; Kattamis A; Jones C; Øra I; Mikkelsen TS; Zapotocky M; Sumerauer D; Scheie D; McCabe M; Wesseling P; Tops BBJ; Kranendonk MEG; Karajannis MA; Bouvier N; Papaemmanuil E; Dohmen H; Acker T; von Hoff K; Schmid S; Miele E; Filipski K; Kitanovski L; Krskova L; Gojo J; Haberler C; Alvaro F; Ecker J; Selt F; Milde T; Witt O; Oehme I; Kool M; von Deimling A; Korshunov A; Pfister SM; Sahm F; Jones DTW
Acta Neuropathol; 2021 Nov; 142(5):841-857. PubMed ID: 34417833
[TBL] [Abstract] [Full Text] [Related]
3. Analysis and identification of novel biomarkers involved in neuroblastoma via integrated bioinformatics.
Chen B; Ding P; Hua Z; Qin X; Li Z
Invest New Drugs; 2021 Feb; 39(1):52-65. PubMed ID: 32772341
[TBL] [Abstract] [Full Text] [Related]
